- Revenues +11.6%, Adjusted EBITDA +13.1% - Organic development compared to pro forma figures Q1 2024: revenues -6.5%, adjusted EBITDA -9.3% - Q1 significantly influenced by revenue shift in syringe business - Guidance 2025 confirmed: organic revenue growth of 3-5% and adjusted EBITDA...
Read More Details
Finally We wish PressBee provided you with enough information of ( Gerresheimer: Bormioli Pharma boosts revenues and earnings )
Also on site :
- 7 Best Ways To Style Linen Pants, According to a Celebrity Stylist
- Peter Weber Goes Public With His Relationship and His Family Has Thoughts
- Rachel Bilson Shares Rare Photo of Briar Rose, Her Daughter with Ex Hayden Christensen